Labiana Health S.A. (LAB) — Capital Reinvestment Ratio

Latest as of December 2022: 1.17x

Labiana Health S.A. (LAB) has a Capital Reinvestment Ratio of 1.17x as of December 2022, meaning it reinvests 1% of its operating cash flow (€4.68 Million) in capital expenditures (€5.45 Million). Check LAB intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.17x
Capex / Operating Cash Flow

Operating Cash Flow

€4.68 Million
EUR

Capital Expenditures

€5.45 Million
EUR

Data as of

Dec 2022
Most recent filing

Labiana Health S.A. Capital Reinvestment Ratio (2021–2025)

This chart tracks Labiana Health S.A.'s Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see LAB cash flow metrics.

Annual Capital Reinvestment Ratio for Labiana Health S.A. (2021–2025)

Year-by-year Capital Reinvestment Ratio for Labiana Health S.A. from 2021 to 2025. See LAB FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 2.61x €1.70 Million €4.44 Million ▲ +516.3%
2024 0.42x €7.19 Million €3.05 Million ▼ -63.7%
2022 1.17x €4.68 Million €5.45 Million ▼ -4.5%
2021 1.22x €3.91 Million €4.77 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow